Literature DB >> 27413631

The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypes.

Agata Page1, Derek A Mann1, Jelena Mann1.   

Abstract

Epigenetics is a dynamically expanding field of science entailing numerous regulatory mechanisms controlling changes of gene expression in response to environmental factors. Over the recent years there has been a great interest in epigenetic marks as a potential diagnostic and prognostic tool or future target for treatment of various human diseases. There is an increasing body of published research to suggest that epigenetic events regulate progression of chronic liver disease. Experimental manipulation of epigenetic signatures such as DNA methylation, histone acetylation / methylation and the activities of proteins that either annotate or interpret these epigenetic marks can have profound effects on the activation and phenotype of HSC, key cells responsible for onset and progression of liver fibrosis. This review presents recent advances in epigenetic alterations, which could provide mechanistic insight into the pathogenesis of chronic liver disease and provide novel clinical applications.

Entities:  

Keywords:  DNA methylation; epigenetics; hepatic stellate cells; histone modyfications; liver fibrosis; microRNAs

Year:  2014        PMID: 27413631      PMCID: PMC4940134          DOI: 10.1007/s40139-014-0052-0

Source DB:  PubMed          Journal:  Curr Pathobiol Rep        ISSN: 2167-485X


  71 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  Multivalent engagement of chromatin modifications by linked binding modules.

Authors:  Alexander J Ruthenburg; Haitao Li; Dinshaw J Patel; C David Allis
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

3.  MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats.

Authors:  Hui Tao; Cheng Huang; Jing-Jing Yang; Tao-Tao Ma; Er-Bao Bian; Lei Zhang; Xiong-Wen Lv; Yong Jin; Jun Li
Journal:  Toxicology       Date:  2011-10-25       Impact factor: 4.221

4.  A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.

Authors:  T Niki; K Rombouts; P De Bleser; K De Smet; V Rogiers; D Schuppan; M Yoshida; G Gabbiani; A Geerts
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

Review 5.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

6.  TGF-beta1 gene silencing for treating liver fibrosis.

Authors:  Kun Cheng; Ningning Yang; Ram I Mahato
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

7.  Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis.

Authors:  J Mann; F Oakley; F Akiboye; A Elsharkawy; A W Thorne; D A Mann
Journal:  Cell Death Differ       Date:  2006-06-09       Impact factor: 15.828

8.  Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.

Authors:  Mohammad R Ebrahimkhani; Fiona Oakley; Lindsay B Murphy; Jelena Mann; Anna Moles; Maria J Perugorria; Elizabeth Ellis; Anne F Lakey; Alastair D Burt; Angela Douglass; Matthew C Wright; Steven A White; Fabrice Jaffré; Luc Maroteaux; Derek A Mann
Journal:  Nat Med       Date:  2011-11-27       Impact factor: 53.440

9.  Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation.

Authors:  Maria Jesus Perugorria; Caroline L Wilson; Mujdat Zeybel; Meagan Walsh; Shilu Amin; Stuart Robinson; Steven A White; Alastair D Burt; Fiona Oakley; Hidekazu Tsukamoto; Derek A Mann; Jelena Mann
Journal:  Hepatology       Date:  2012-09       Impact factor: 17.425

10.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

Authors:  Jelena Mann; David C K Chu; Aidan Maxwell; Fiona Oakley; Nian-Ling Zhu; Hidekazu Tsukamoto; Derek A Mann
Journal:  Gastroenterology       Date:  2009-10-17       Impact factor: 22.682

View more
  5 in total

Review 1.  Mechanosensing and fibrosis.

Authors:  Daniel J Tschumperlin; Giovanni Ligresti; Moira B Hilscher; Vijay H Shah
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

2.  Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis (Review).

Authors:  Niladri Ganguly; Subrata Chakrabarti
Journal:  Int J Mol Med       Date:  2021-01-26       Impact factor: 4.101

Review 3.  Cell-Based Mechanosensation, Epigenetics, and Non-Coding RNAs in Progression of Cardiac Fibrosis.

Authors:  Silvia Ferrari; Maurizio Pesce
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

4.  Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways.

Authors:  Linli Yang; Bo Han; Man Zhang; Ya-Hui Wang; Kun Tao; Michael X Zhu; Kunyan He; Zhi-Gang Zhang; Shangwei Hou
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810

Review 5.  Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?

Authors:  Alex Claveria-Cabello; Leticia Colyn; Maria Arechederra; Jesus M Urman; Carmen Berasain; Matias A Avila; Maite G Fernandez-Barrena
Journal:  Cells       Date:  2020-10-19       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.